|
1）Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 2014; 15: e517-26
|
|
|
|
2）Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007; 7: 270-80
|
|
|
|
|
|
3）Yamagishi M, Watanabe T. Molecular hallmarks of adult T cell leukemia. Front Microbiol. 2012; 3: 334
|
|
|
|
|
|
4）Sakashita A, Hattori T, Miller CW, et al. Mutations of the p53 gene in adult T-cell leukemia. Blood. 1992; 79: 477-80
|
|
|
|
|
|
5）Tamiya S, Etoh K, Suzushima H, et al. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood. 1998; 91: 3935-42
|
|
|
|
|
|
6）Yamada Y, Hatta Y, Murata K, et al. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. J Clin Oncol. 1997; 15: 1778-85
|
|
|
|
|
|
7）Hidaka T, Nakahata S, Hatakeyama K, et al. Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma. Blood. 2008; 112: 383-93
|
|
|
|
|
|
8）Kataoka K, Nagata Y, Kitanaka A, et al. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet. 2015; 47: 1304-15
|
|
|
|
|
|
9）Koss H, Bunney TD, Behjati S, et al. Dysfunction of phospholipase Cgamma in immune disorders and cancer. Trends Biochem Sci. 2014; 39: 603-11
|
|
|
|
|
|
10）Vaque JP, Gomez-Lopez G, Monsalvez V, et al. PLCG1 mutations in cutaneous T-cell lymphomas. Blood. 2014; 123: 2034-43
|
|
|
|
|
|
11）Paul S, Schaefer BC. A new look at T cell receptor signaling to nuclear factor-kappaB. Trends Immunol. 2013; 34: 269-81
|
|
|
|
|
|
12）Thome M, Charton JE, Pelzer C, et al. Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harbor perspectives in biology. 2010; 2: a003004
|
|
|
|
|
|
13）Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Ann Rev Immunol. 2009; 27: 693-733
|
|
|
|
|
|
14）Antal CE, Hudson AM, Kang E, et al. Cancer-associated protein kinase C mutations reveal kinaseʼs role as tumor suppressor. Cell. 2015; 160: 489-502
|
|
|
|
|
|
15）Lenz G, Davis RE, Ngo VN, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008; 319: 1676-9
|
|
|
|
|
|
16）Sommer K, Guo B, Pomerantz JL, et al. Phosphorylation of the CARMA1 linker controls NF-kappaB activation. Immunity. 2005; 23: 561-74
|
|
|
|
|
|
17）Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013; 13: 227-42
|
|
|
|
|
|
18）Yoshie O, Fujisawa R, Nakayama T, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood. 2002; 99: 1505-11
|
|
|
|
|
|
19）Hasegawa H, Nomura T, Kohno M, et al. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood. 2000; 95: 30-8
|
|
|
|
|
|
20）Ishida T, Joh T, Uike N, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol. 2012; 30: 837-42
|
|
|
|
|
|
21）Nakagawa M, Schmitz R, Xiao W, et al. Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma. J Exp Med. 2014; 211: 2497-505
|
|
|
|
|
|
22）Yamagishi M, Nakano K, Miyake A, et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer cell. 2012; 21: 121-35
|
|
|
|
|
|
23）Feschotte C, Gilbert C. Endogenous viruses: insights into viral evolution and impact on host biology. Nat Rev Genet. 2012; 13: 283-96
|
|
|
|
|
|
24）Najafabadi HS, Mnaimneh S, Schmitges FW, et al. C2H2 zinc finger proteins greatly expand the human regulatory lexicon. Nat Biotech. 2015; 33: 555-62
|
|
|
|
|
|
25）Wolf D, Goff SP. Embryonic stem cells use ZFP809 to silence retroviral DNAs. Nature. 2009; 458: 1201-4
|
|
|
|
|
|
26）Bhatia A, Kumar Y. Cellular and molecular mechanisms in cancer immune escape: a comprehensive review. Exp Rev Clin Immunol. 2014; 10: 41-62
|
|
|
|
|
|
27）Boxus M, Twizere JC, Legros S, et al. The HTLV-1 Tax interactome. Retrovirology. 2008; 5: 76
|
|
|
|
|